Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)
CNY 47.4
(8.72%)
CNY 47.4
(8.72%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 354.54 Million CNY | -17.35% |
| 2022 | 248.83 Million CNY | -29.15% |
| 2021 | 345.55 Million CNY | -41.92% |
| 2020 | 581.14 Million CNY | -7.52% |
| 2019 | 638.97 Million CNY | 34.92% |
| 2018 | 508.82 Million CNY | 27.78% |
| 2017 | 375.07 Million CNY | 41.12% |
| 2016 | 282.43 Million CNY | -12.18% |
| 2015 | 298.43 Million CNY | -0.18% |
| 2014 | 298.98 Million CNY | 19.84% |
| 2013 | 246.98 Million CNY | 17.89% |
| 2012 | 211.5 Million CNY | 5.99% |
| 2011 | 199.76 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 86.72 Million CNY | -22.49% |
| 2024 Q1 | 137.12 Million CNY | -2.53% |
| 2024 Q3 | 58.96 Million CNY | -42.02% |
| 2023 Q3 | 31.59 Million CNY | -55.1% |
| 2023 Q2 | 70.36 Million CNY | -29.35% |
| 2023 Q1 | 99.59 Million CNY | 57.93% |
| 2023 FY | - CNY | -17.35% |
| 2023 Q4 | 23.55 Million CNY | -25.45% |
| 2022 Q4 | 63.06 Million CNY | 416.2% |
| 2022 Q3 | 12.21 Million CNY | -82.51% |
| 2022 Q1 | 70.95 Million CNY | -54.54% |
| 2022 Q2 | 69.86 Million CNY | -1.53% |
| 2022 FY | - CNY | -29.15% |
| 2021 Q3 | -59.67 Million CNY | -154.54% |
| 2021 FY | - CNY | -41.92% |
| 2021 Q1 | 116.56 Million CNY | -28.71% |
| 2021 Q2 | 109.41 Million CNY | -6.14% |
| 2021 Q4 | 156.09 Million CNY | 361.58% |
| 2020 Q2 | 198.79 Million CNY | 56.99% |
| 2020 Q3 | 88.08 Million CNY | -55.69% |
| 2020 FY | - CNY | -7.52% |
| 2020 Q4 | 163.5 Million CNY | 85.62% |
| 2020 Q1 | 126.63 Million CNY | -46.69% |
| 2019 Q3 | 95.22 Million CNY | -44.06% |
| 2019 Q1 | 138.8 Million CNY | -27.99% |
| 2019 FY | - CNY | 34.92% |
| 2019 Q4 | 237.52 Million CNY | 149.44% |
| 2019 Q2 | 170.23 Million CNY | 22.65% |
| 2018 Q2 | 116.19 Million CNY | -3.07% |
| 2018 FY | - CNY | 27.78% |
| 2018 Q4 | 192.74 Million CNY | 372.73% |
| 2018 Q3 | 40.77 Million CNY | -64.91% |
| 2018 Q1 | 119.87 Million CNY | 0.0% |
| 2017 FY | - CNY | 41.12% |
| 2016 FY | - CNY | -12.18% |
| 2015 FY | - CNY | -0.18% |
| 2014 FY | - CNY | 19.84% |
| 2013 FY | - CNY | 17.89% |
| 2012 FY | - CNY | 5.99% |
| 2011 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Liuzhou Liangmianzhen Co., Ltd. | 59.28 Million CNY | -498.056% |
| Shanghai Jahwa United Co., Ltd. | 864.85 Million CNY | 59.005% |
| Henan Rebecca Hair Products Co., Ltd. | 197.77 Million CNY | -79.267% |
| Perfect Group Corp., Ltd | 168.89 Million CNY | -109.92% |
| RUNBEN BIOTECHNOLOGY | 290.05 Million CNY | -22.236% |
| Proya Cosmetics Co.,Ltd. | 1.62 Billion CNY | 78.187% |
| Lafang China Co.,Ltd | 86.16 Million CNY | -311.453% |
| Shanghai Flyco Electrical Appliance Co., Ltd. | 1.38 Billion CNY | 74.414% |
| Hangzhou Haoyue Personal Care Co., Ltd | 643.75 Million CNY | 44.925% |